ReviewJournal of ovarian research2025
Molecular, cellular, biochemical, and rehabilitative insights into exercise interventions for gynecological cancer prevention and survivorship: a narrative review.
Review in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Total moderate-to-vigorous physical activity across the adult life course and the risk of invasive ovarian cancer.International journal of epidemiology · 2026Article
- P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice.Purinergic signalling · 2026Article
- Exercise and physiotherapy for enhancing muscle strength, managing lower-limb lymphedema, and improving sexual function in the treatment and survivorship of gynecological cancers.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review paper investigated existing literature on the relationship between physical activity, exercise, and gynecological cancers, focusing on ovarian, endometrial, and cervical cancers. Epidemiological studies consistently demonstrate an inverse association between physical activity levels and the risk of developing gynecological cancers, as well as improved survival outcomes among cancer survivors engaging in regular exercise. Mechanistic insights suggest that physical activity and exercise may modulate key pathways involved in carcinogenesis, tumor progression, and treatment response, offering promising avenues for preventive and adjunctive therapeutic interventions. However, despite a growing body of research in exercise oncology, there is a lack of disease-specific synthesis addressing how exercise can be tailored to the distinct pathophysiological, treatment-related, and psychosocial challenges of gynecological cancers. Current guidelines often generalize exercise recommendations across all cancer types, overlooking the unique symptom burdens, such as pelvic floor dysfunction, sarcopenia, and menopausal symptoms, specific to gynecologic malignancies. This review addresses this gap by examining the evidence base for exercise in ovarian, endometrial, and cervical cancers, with an emphasis on mechanistic, clinical, and rehabilitative dimensions. By integrating epidemiological findings with preclinical and intervention data, this work aims to establish a gynecologic-specific framework for exercise prescription. This review underscores the importance of multidisciplinary research efforts to optimize lifestyle interventions, inform evidence-based guidelines, and improve outcomes for individuals affected by gynecological cancers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.